Skip to main navigation Skip to search Skip to main content

Endophthalmitis after dropless (Tri-Moxi injection) cataract surgery

Research output: Contribution to journal › Article › peer-review

Abstract

Introduction: A case of endophthalmitis after dropless cataract surgery with intravitreal Tri-Moxi associated with severe vision loss. Case summary: An 82-year-old male developed severe vision loss in the left eye 24 days after dropless cataract surgery with intravitreal Tri-Moxi injection. Best corrected visual acuity was hand motion in the left eye. Intraocular pressure was 13, with inferior keratic precipitates, 4 + cell with 1 mm layered hypopyon, and a plaque on the posterior capsule that blocked direct exam of the posterior segment. Ultrasonography revealed extensive vitritis without retinal or choroidal detachments. Conclusion: Endophthalmitis resolved and vision improved after management with vitreous tap, intravitreal and fortified topical antibiotics, and subsequent prompt pars plana vitrectomy. Vitreous sample grew fluoroquinolone-resistant staphylococcus epidermidis.

Original languageEnglish
Pages (from-to)NP29-NP31
JournalEuropean Journal of Ophthalmology
Volume30
Issue number5
DOIs
StatePublished - Sep 1 2020

ASJC Scopus Subject Areas

  • Ophthalmology

Keywords

  • Dropless cataract surgery
  • Tri-Moxi
  • endophthalmitis
  • intravitreal injection

Cite this